Literature DB >> 94035

A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication.

E Y Lasfargues, W G Coutinho, A S Dion.   

Abstract

A human breast tumor cell line BT-474 derived from an invasive ductal carcinoma was experimentally infected in vitro with a mouse mammary tumor virus from the TIII strain (RIII-MuMTV). The virus that replicated in the human cells was characterized as a mouse virus by immunofluorescence, electron microscopy and the presence of a specific RNA-directed DNA polymerase. The cells themselves were human as per the karyotype and isoenzyme migration patterns. It is concluded that human cells are susceptible to the mouse mammary tumor virus and can, eventually, support its replication.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 94035     DOI： 10.1007/bf02618252

Source DB:  PubMed          Journal:  In Vitro        ISSN： 0073-5655


  18 in total

1.  Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.

Authors:  M M Black; R E Zachrau; B Shore; A S Dion; H P Leis
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

2.  Isolation of two human tumor epithelial cell lines from solid breast carcinomas.

Authors:  E Y Lasfargues; W G Coutinho; E S Redfield
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

3.  An antigen in human breast cancer sera related to the murine mammary tumour virus.

Authors:  M Müller; H Grossman
Journal:  Nat New Biol       Date:  1972-05-24

4.  Immunological studies on human breast carcinoma and mouse mammary tumors.

Authors:  E S Priori; D E Anderson; W C Williams; L Dmochowski
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

5.  Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA viruses.

Authors:  J Schlom; S Spiegelman
Journal:  Science       Date:  1971-11-19       Impact factor: 47.728

6.  Cation preferences for poly(rC)-oligo(dG)-directed DNA synthesis by RNA tumor viruses and human milk particulates.

Authors:  A S Dion; A B Vaidya; G S Fout
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

7.  Search for a human breast cancer virus.

Authors:  D H Moore; J Charney; B Kramarsky; E Y Lasfargues; N H Sarkar; M J Brennan; J H Burrows; S M Sirsat; J C Paymaster; A B Vaidya
Journal:  Nature       Date:  1971-02-26       Impact factor: 49.962

8.  Precursor-product relationship between nonglycosylated polypeptides of A and B particles of mouse mammary tumor virus.

Authors:  H Tanaka
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

9.  Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells.

Authors:  N S Yang; C M McGrath; P Furmanski
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

10.  Studies on the relationship of viruses to the origin of human breast cancer. II. Viruslike particles in human breast tumors.

Authors:  G Seman; B Myers; W C Williams; H S Gallager; L Dmochowski
Journal:  Tex Rep Biol Med       Date:  1969
View more
  10 in total

1.  Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Authors:  Yayun Liang; Cynthia Besch-Williford; Indira Benakanakere; Philip E Thorpe; Salman M Hyder
Journal:  Breast Cancer Res Treat       Date:  2010-03-27       Impact factor: 4.872

2.  SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.

Authors:  Marjan E Askarian-Amiri; Joanna Crawford; Juliet D French; Chanel E Smart; Martin A Smith; Michael B Clark; Kelin Ru; Tim R Mercer; Ella R Thompson; Sunil R Lakhani; Ana C Vargas; Ian G Campbell; Melissa A Brown; Marcel E Dinger; John S Mattick
Journal:  RNA       Date:  2011-04-01       Impact factor: 4.942

3.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 4.  MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue.

Authors:  Susan R Ross
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

5.  Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus.

Authors:  T H Stewart; R D Sage; A F Stewart; D W Cameron
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

6.  Single amino acid substitution (G42E) in the receptor binding domain of mouse mammary tumour virus envelope protein facilitates infection of non-murine cells in a transferrin receptor 1-independent manner.

Authors:  Constantine James Konstantoulas; Benjamin Lamp; Tillman Hans Rumenapf; Stanislav Indik
Journal:  Retrovirology       Date:  2015-05-16       Impact factor: 4.602

7.  A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.

Authors:  Farah B Rahmatpanah; Zhenyu Jia; Xin Chen; Jessica E Char; Bozhao Men; Anna-Clara Franke; Frank E Jones; Michael McClelland; Dan Mercola
Journal:  Oncotarget       Date:  2015-01-20

8.  Prevalence and characteristics of mouse mammary tumor virus-like virus associated breast cancer in China.

Authors:  Fa-Liang Wang; Xiao-Li Zhang; Ming Yang; Jun Lin; Yong-Fang Yue; Ya-Dan Li; Xian Wang; Qiang Shu; Hong-Chuan Jin
Journal:  Infect Agent Cancer       Date:  2021-06-26       Impact factor: 2.965

9.  Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells.

Authors:  Enxiu Wang; Nyamekye Obeng-Adjei; Qihua Ying; Laurent Meertens; Tanya Dragic; Robert A Davey; Susan R Ross
Journal:  Virology       Date:  2008-10-01       Impact factor: 3.616

10.  Is MMTV associated with human breast cancer? Maybe, but probably not.

Authors:  Raisa Perzova; Lynn Abbott; Patricia Benz; Steve Landas; Seema Khan; Jordan Glaser; Coleen K Cunningham; Bernard Poiesz
Journal:  Virol J       Date:  2017-10-13       Impact factor: 4.099
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.